MedTrace Logo

New Technologies to Help Manage ADHD

NCT02390791 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 85

Last updated 2019-09-13

Study results available
· View outcomes & findings →

Summary

Cluster randomized controlled trial to evaluate the general effectiveness of intervention compared to control on medication continuity as measured by prescriptions written and other more proximal outcomes during the first six months of treatment.

Conditions

  • Attention Deficit Hyperactivity Disorder

Interventions

OTHER

enhanced myADHDportal.com

Version of the myADHDportal.com web software enhanced with family-management support to enable parents to be active partners in optimizing and maintaining medication continuity for their child

OTHER

treatment as usual standard portal

Standard version of myADHDportal.com web software

Sponsors & Collaborators

  • National Institute of Mental Health (NIMH)

    collaborator NIH

  • Children's Hospital Medical Center, Cincinnati

    lead OTHER

Principal Investigators

  • William Brinkman, MD, MEd, MSc · Cincinnati Children's

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
6 Years
Max Age
10 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-09-30
Primary Completion
2017-08-31
Completion
2017-08-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02390791 on ClinicalTrials.gov